eli lilly news - Search News

Eli Lilly to join lawsuit over GLP-1 shortage

YAHOO!Finance · 12h

Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks 'Swift End' And 'To Protect Its Interests'

As expected by many, Eli Lilly And Co (NYSE:LLY) filed a motion to intervene as a defendant in a case between the Outsourcing Facilities Association and FarmaKeio Custom Compounding against the FDA. The court has now ordered the Outsourcing Facilities Association to respond by January 15,

Hosted on MSN · 13h

Eli Lilly asks to join FDA in opposing lawsuit from pharmacies

CNBC's Becky Quick reports on news from Eli Lilly. US surgeon general urges cancer warnings for alcoholic drinks 14 Trader Joe's Items That Have Gained a Cult Following for a Good Reason

Becker's Hospital Review · 4h

Eli Lilly to join lawsuit over GLP-1 shortage: 4 things to know

Eli Lilly is joining in a lawsuit filed by the Outsourcing Facilities against the FDA, aiming to reverse the FDA's October 2024 determination that the shortage has been resolved, which would allow compounding pharmacies to continue selling unapproved versions of the drugs, according to court documents obtained by Becker's .

Seeking Alpha on MSN · 1d

Lilly seeking to join lawsuit over compounded GLP-1 drugs

Eli Lilly (NYSE:LLY) is reportedly seeking to oppose a lawsuit filed by compounding pharmacies over the FDA's determination that weight-loss and diabetes drugs such as Lilly's (NYSE:LLY) tirzepatide are no longer in short supply.

2don MSN

Drug-Trial Results Could Shake Up Pharma Stocks in 2025. Watch Eli Lilly, Pfizer, and More.

Here are some clinical trials that could send Big Pharma shares soaring, or crashing, in 2025. Eli Lilly. The world’s biggest ...

8d

Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear.

Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...

14d

The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be next

Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug ...

13d

Is Now a Good Time to Buy the Dip in Eli Lilly Stock?

Since pharmaceutical giant Eli Lilly (NYSE: LLY) reported earnings for the third quarter on Oct. 30, shares have been ...

5d

Is Eli Lilly Stock a Buy?

Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 ...

CNBC on MSN14d

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

The Food and Drug Administration approved Eli Lilly's blockbuster weight loss drug Zepbound for treating patients with ...

7d

Eli Lilly & Co. stock underperforms Friday when compared to competitors

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

13don MSN

Novo Nordisk raises expectations for Eli Lilly after CagriSema slipup

Novo Nordisk (NVO) increased valuation gap with Eli Lilly (LLY) after its Phase 3 data for next-gen weight loss drug ...

13d

Eli Lilly to test weight loss drug Zepbound to treat addiction

Weight loss injections have become a popular choice to help people curb their appetite, but can they curb addiction, as well?

Roche projected to claim pharma's 2025 sales crown as Novo, Lilly climb rankings: Evaluate

The story of Eli Lilly and Novo Nordisk’s GLP-1 dominance is likely to play out again in 2025 as the metabolic medicine ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results